基本信息
文件名称:Cibenzoline-d4-Cifenline-d-sub-4-sub-生命科学试剂-MCE.pdf
文件大小:473.18 KB
总页数:1 页
更新时间:2025-05-22
总字数:约3.39千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

Cibenzoline-d4

Cat.No.:HY-106577S

Synonyms:Cifenline-d;Ro22-7796-d

44

分?式:C??H??D?N?

分?量:266.37

作?靶点:Isotope-LabeledCompounds;PotassiumChannel

作?通路:Others;MembraneTransporter/IonChannel

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性Cibenzoline-d4(Cifenline-d4)是氘代标记的Cibenzoline.Cibenzoline是Ia类抗?律失常活性分?,其抗胆

碱能活性较低。Cibenzoline是KATP通道抑制剂,通过成孔亚基Kir6.2发挥作?,IC50为22.2μM。

Cibenzoline可抑制IKr和IKs电流,IC50分别为8.8μM和12.3μM。Cibenzoline可?于?肌疾病的研究。

此外,Cibenzoline还具有降?糖的作?[1][2][3][4]。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdevelopmentprocess.Deuterationhasgainedattention

becauseofitspotentialtoaffectthepharmacokineticandmetabolicprofilesofdrugs.

RE